Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Mansi Sharma's publication output changed over time?
ScholarIQpublication output · 2018–2024
Output declined50% over the shown period — from 2 works in 2018 to 1 in 2024.
2
1
3
3
1
1
201820192020202120232024
What are the most-cited papers on Mansi Sharma?
ScholarIQmost cited works
Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
Praveen Jain, Dinesh Chandra Doval, Ullas Batra, Pankaj Goyal, Sneha Bothra, Chaturbhuj Agarwal, Dutta Kumardeep Choudhary, Abhishek Yadav, Venkata Pradeep Babu Koyalla, Mansi Sharma, Prashanta Dash, Vineet Talwar
S149902429. 201955 Citations
IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?
Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Sunil Pasricha, Abhishek Bansal, Parveen Jain, Anurag Mehta
S37362813. 202127 Citations
EML4-ALK Fusion as a Resistance Mechanism to Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature
Ullas Batra, Mansi Sharma, B. P. Amrith, Anurag Mehta, Praveen Jain
Clinical Lung Cancer. 202025 Citations
COVID-19 vaccination status in Indian patients with cancer
Ullas Batra, Shrinidhi Nathany, N.K. Bansal, Mansi Sharma
S4210179561. 202118 CitationsOPEN ACCESS
Biomarker testing in non-small cell lung carcinoma – More is better: A case series
Ullas Batra, Mansi Sharma, Shrinidhi Nathany, Satyajeet Soni, Abhishek Bansal, Parveen Jain, Anurag Mehta
S4210179561. 202015 CitationsOPEN ACCESS
Related on ScholarIQ
Amity University
Institution
Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
Paper
IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?
Paper
EML4-ALK Fusion as a Resistance Mechanism to Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature
Paper
COVID-19 vaccination status in Indian patients with cancer
Paper
Biomarker testing in non-small cell lung carcinoma – More is better: A case series
Paper